Resources

Results 626 - 650 of 1357

Moving the global response towards the universal test and treat model will pose huge challenges to public health systems in resource-limited settings, including global and local supply chain systems. These challenges are especially acute in Africa, which accounts for over 70% of the persons affected by HIV.To ensure that there are enough anti-retrovirals available to treat the nearly 25 million people that will require them by 2020 represents a near doubling of the ARV supplied to treat the 13 million currently on treatment. Similarly, to monitor those on treatment means an unprecedented scale-up of viral load testing throughout Africa. Larger issues include whether the capacity exists at the local level to handle these commodities when they arrive in the most severely affected countries, including considerations of the human resources and costs needed to make this strategy effective. We believe that such ‘‘real world’’ analysis of proposed strategies and policies is essential to ensure their most effective implementation.

In this opinion paper, we discuss lessons learned from the global scale-up of these laboratory devices and the pathway to tapping the potential of laboratory-generated information in the field of TB by using connectivity. Responding to the demand for connectivity, innovative third-party players have proposed solutions that have been widely adopted by field users of the Xpert® MTB/RIF assay. The experience associated with the utilisation of these systems, which facilitate the monitoring of wide laboratory networks, stressed the need for a more global and comprehensive approach to diagnostic connectivity. In addition to facilitating the reporting of test results, the mobility of digital information allows the sharing of information generated in programme settings. When they become easily accessible, these data can be used to improve patient care, disease surveillance and drug discovery. We list several examples of initiatives that should allow data sources to be combined to improve the understanding of the epidemic, support the operational response and, finally, accelerate TB elimination.

Return of Organization Exempt from Income Tax Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code

These briefing cards detail the linkages between sexual and reproductive health and rights (SRHR) and other key development issues including environmental sustainability, gender equality, economic growth, educational attainment, and broader health goals.

Advocating Together: The Power of Alliances for Maternal Health provides guidance for national civil society organizations (CSOs) interested in establishing or strengthening an alliance in support of maternal health advocacy. This toolkit provides a step-by-step approach to working with partners in a national-level alliance to advocate for maternal health policy change.

The past decade has witnessed increasing global attention and political support for maternal, newborn and child health. Despite this increased attention, actual progress has been slow and sporadic: coverage of key maternal and newborn health interventions remains low and there are wide disparities in access to care, within and across countries.

Maternal health remains an urgent public health challenge for the global community.

Obstetric fistula is an injury to the birth canal, resulting from prolonged labour, that has devastating physical and psychological effects on women's lives.

Obstetric fistula is an injury to the birth canal, resulting from prolonged labour, that has devastating physical and psychological effects on women's lives. Its persistence reveals vast inequities in access to and quality of reproductive health care.

In 2013, Family Care International (FCI) conducted a mapping analysis in Zambia to gather information on the maternal health policy environment; the organizations, partnerships, and networks currently and potentially engaged in maternal health advocacy; and the advocacy goals, strategies, resources, and core messages being used.

In 2012-2013, Family Care International conducted a mapping analysis in Uganda to gather information on the maternal health policy environment; the organizations, partnerships, and networks currently and potentially engaged in maternal health advocacy; and the advocacy goals, strategies, resources, and core messages being used.

Mobilising Communities on Young People's Health and Rights: An Advocacy Toolkit for Programme Managers leads the user through the stages of planning and launching an advocacy campaign to ensure that government commitments are translated into programs that meet young people's sexual and reproductive health needs.

National Essential Medicines lists (EMLs) indicate medicines that meet the priority health needs of the population and often guide a government’s purchasing and distribution decisions for public health facilities.

This infographic, developed with support from Johnson & Johnson, highlights the critical role that midwives play in improving maternal and newborn health around the world. Midwives have a powerful voice in changing policies and practices that support the availability, accessibility, acceptability, and quality of health services.

Plaidoyer, approbation, accés : le misoprostol pour l'Hémorragie du post-partum Guide pour un plaidoyer efficace (French title)

Developed by Family Care International on behalf of the Reproductive Health Supplies Coalition (RHSC), this set of 7 policy briefs identifies key challenges and strategies for increasing the availability of three essential maternal health medicines: oxytocin, misoprostol, and magnesium sulfate, which can prevent or treat the leading causes of maternal death (postpartum hemorrhage and pre-eclampsia

This publication presents case studies from three countries — Bangladesh, Nepal, and Zambia — that have introduced and scaled up the use of misoprostol for postpartum hemorrhage (PPH).

East Africa, Latin America and the Caribbean, Middle East and North Africa, South Asia, Francophone West Africa

Developed by Family Care International and Gynuity Health Projects, the Misoprostol for Postpartum Hemorrhage Information Kit contains four publications. Postpartum Hemorrhage: A Challenge for Safe Motherhood

This policy brief, published by FCI in partnership with Gynuity Health Projects, PATH, and FIGO, explores strategies to help governments and partners improve maternal health by expanding access to misoprostol for postpartum hemorrhage (PPH), one of the leading causes of maternal death.

In recent years, the Government of Kenya has endorsed a range of global and regional initiatives for accelerating action to improve the health and well-being of women and their children, including the Global Strategy for Women's and Children's Health, the Maputo Plan of Action, and CARMMA, and has made specific commitments to achieve them.

This fact sheet presents an overview of the Mobilizing Advocates from Civil Society (MACS) project led by FCI from 2012 to 2015.

This video highlights the critical role of civil society organizations and alliances in holding governments accountable for fulfilling their commitments to protect women's and children's lives, health, and wellbeing, especially among the poorest and most vulnerable.

In this video, Family Care International (FCI) makes the case for clear and transparent national budgets that reflect the people's needs and priorities and that fulfill government commitments to protect the health and well-being of all women, newborns, and children.

A government budget must be comprehensive and transparent to allow citizens to hold government accountable for managing public funds.

Pages